Article
Dr. Jack Cush interviews Professor Edward Keystone, MD (University of Toronto) on the origins and science behind the 60/40/20 benchmark and outcomes in rheumatoid arthritis.
All News
Article
The arsenal of therapeutics for psoriatic arthritis continues to increase. Risankizumab is an IL-23 inhibitor to the p19 subunit, currently being investigated for treatment of psoriatic arthritis.
Article
Appropriate assessment and management of comorbidities and multimorbidity in patients with RA is vital for overall health and well-being of the patient, as well as to encourage treatment adherence, and address social, psychological and quality of life factors.
Article
Little is known about the safety of newer biologic use during pregnancy, especially in patients who either conceive while on a biologic or must remain on a biologic during pregnancy (often the case with IBD and inflammatory arthritis).
Article
Growing awareness of spondyloarthropathies over the last two decades has led to a better understanding of the pathophysiology of spondyloarthritis, and subsequently increased interest in more distinct, disease state specific treatment options.
Dr. John Cush
Tweet
ICYMI: Drs. Jeffrey Sparks, Greg McDermott and Vanessa Kronzer discuss work in the area of respiratory disease in RA, mucosal paradigm, RA-ILD, bronchiectasis, as well as their experience as virtual attendees at the #ACR21 annual meeting.
https://t.co/5BrxeJBWM2 https://t.co/m8CqyJ1L7A
Dr. John Cush
Tweet
RheumNow Podcast - 60/40/20 Interview with Dr. Ed Keystone
https://t.co/simAKtsQ7q
Dr. John Cush
Tweet
ICYMI: Uveitis and Prevalence of Psoriasis in axSpA: Dr. Robert Chao ( @doctorRBC) discusses the best SpA abstracts he saw at the #ACR21 annual meeting: abstracts #1324 and #1311.
https://t.co/XEJMyvKDnx
Dr. John Cush
Tweet
ICYMI: COVID-19 in Patients with Primary Systemic Vasculitis and Polymyalgia Rheumatica
Dr. Bella Mehta ( @bella_mehta) interviews Dr. Sebastian Sattui about abstract #0952 presented at the #ACR21 annual meeting.
https://t.co/UN66qOGqRd
Dr. John Cush
Tweet
ICYMI: Does Control of Inflammation Lower Cancer Risk?
https://t.co/OBMIdPki7O https://t.co/zV04iAOjAz
Dr. John Cush
Tweet
ICYMI: Multimorbidity, the presence of multiple overlapping chronic comorbid conditions, is increasingly common at first presentation of rheumatoid arthritis (RA), increasing as a person gets older and/or during disease progression.
https://t.co/CL2xEyjKmd https://t.co/inoyahbkM9
Dr. John Cush
Tweet
Food for Thought: "ITIS" Diet for Patients with Rheumatoid Arthritis: Dr. Akhil Sood ( @AkhilSoodMD)
discusses abstract #1699 presented at the ACR21 annual meeting.
https://t.co/wSPuGimFjP https://t.co/nc7bg1Odjk
Dr. John Cush
Tweet
Infection Risk in Offspring Exposed to Biologics: Dr. Rachel Tate ( @uptoTate)
https://t.co/oYpKpCix7Q https://t.co/0yIk9Qhc1h
Dr. John Cush
Tweet
Dr. Janet Pope and Dr. Jeffrey Sparks discuss the importance of lung and several lung-related abstracts presented at the ACR21 annual meeting.
https://t.co/s5sl6tdKwP
Dr. John Cush
Tweet
RheumNow Podcast - 60/40/20 Interview with Dr. Ed Keystone
https://t.co/gLUfazvsXA
Dr. John Cush
Tweet
Multimorbidity, the presence of multiple overlapping chronic comorbid conditions, is increasingly common at first presentation of rheumatoid arthritis (RA), increasing as a person gets older and/or during disease progression.
https://t.co/L6NJhVwOws https://t.co/GgRSCaYTZ6
Dr. John Cush
Tweet
"The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself. Therefore, all progress depends on the unreasonable man."
- George Bernard Shaw https://t.co/9bAJfkF7lH
Dr. John Cush
Tweet
Flare Patterns in Autoinflammatory Syndrome During Pandemic: Dr. Yuz Yusof ( @Yuz6Yusof) discusses abstract #1083 presented at the #ACR21 annual meeting.
https://t.co/i0VU3NEe7F https://t.co/DZkB5TgG3N
Dr. John Cush
Tweet
RA Treatment Conundrums: Dr. Janet Pope ( @Janetbirdope ) reviews abstracts #1252, #1442, #1438, #1444 and #1443 at the #ACR21 annual meeting.
https://t.co/ftlRAq0CNK https://t.co/nnT37wG8l9
Dr. John Cush
Tweet
Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of labs in infections vs. flares Drs.Cush, Yusof, Mehta, Petryna and Tate review autoinflammatory data presented at #ACR21. @Yuz6Yusof @bella_mehta @DrPetryna @uptoTate https://t.co/oeAprkSBWZ https://t.co/1g9yRRFJqf
